It posits that the increase in amyloid-β (Aβ) is the key event in AD that triggers downstream the Tau pathology (hyperphosphorylation, truncation and misfolding) leading to early synaptic deterioration and, then, memory impairment followed by late neuronal death. Here, MAPT is linked to Alzheimer disease.